Amgen (NQ:AMGN)

402.98 -0.06 (-0.01%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

72 73 Next >

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors ↗

May 12, 2024

The biotech's pipeline extends far beyond this exciting weight-loss product.

Via The Motley Fool

5 Stocks Driving Dow's Market-Beating Performance ↗

May 11, 2024

While 27 of the 30 members of the Dow Jones Index have performed well over the last seven days, we have highlighted five of them that have been leading the way higher.

Via Talk Markets

Topics Stocks

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 ↗

May 09, 2024

The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.

Via InvestorPlace

Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday ↗

May 09, 2024

Via Benzinga

Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level ↗

May 09, 2024

Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday.

Via Benzinga

Topics Stocks

Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street ↗

May 09, 2024

Discover the reasons behind three stocks attracting investor attention as they stand on the precipice of future growth.

Via InvestorPlace

Dow Jones Industrial Average Pushes Higher On Wednesday Despite Tepid Risk Appetite ↗

May 08, 2024

Via Talk Markets

Topics Stocks

Market Whales and Their Recent Bets on AMGN Options ↗

May 08, 2024

Via Benzinga

3 Tried and True Dividend Stocks to Buy for Your Portfolio ↗

May 07, 2024

These dividend stocks to buy represent time-tested companies with significant growth potential. Dive in now to strengthen your portfolio.

Via InvestorPlace

How Is The Market Feeling About Amgen? ↗

May 07, 2024

Via Benzinga

The Option Market Shows The Way Through This Low-Volume, Fed-Driven Melt-Up ↗

May 06, 2024

The S&P 500 ended today’s session a little more than 1% higher than where it started. At the same time, trading volume in equities has been very light.

Via Talk Markets

Topics Stocks

Check Out What Whales Are Doing With AMGN ↗

May 06, 2024

Via Benzinga

Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday ↗

May 06, 2024

Via Benzinga

Market Briefing For Monday, May 6, 2024 ↗

May 06, 2024

So prospects for a Fed rate-cut are enhanced by 'mediocre or bad' news on Jobs and Manufacturing fronts. Not a lot; but helps as at least it's not particularly more inflationary; and not a bad...

Via Talk Markets

Topics Economy

Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update ↗

May 05, 2024

As the demand for obesity drugs continues to surge, biopharma companies are eagerly seizing the opportunity to capitalize on the trend.

Via Benzinga

Dow Jones Industrial Average Gains 450 Points As Investors Up Rate Cut Bets After Softer NFP ↗

May 03, 2024

The Dow Jones Industrial Average gained nearly 1.2% on Friday after a broad miss from US Nonfarm Payrolls) and other key labor data revealed a steep weakening in the US domestic economy, sparking...

Via Talk Markets

Topics Economy Stocks

Why Amgen Stock Zoomed Nearly 12% Higher Today ↗

May 03, 2024

The company delivered solid quarterly results, but its discussion of an investigational drug is what really gave its shares a pop.

Via The Motley Fool

Stocks Rally As Jobs Report Rekindles Rate Cut Hopes, Apple Rockets, Bitcoin Soars Above $61,000: What's Driving Markets Friday? ↗

May 03, 2024

A weaker-than-expected jobs report sparked a widespread market rally in the last session of the week, as traders increased expectations on potential interest rate cuts later this year.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review ↗

May 03, 2024

The Nasdaq regained its 50-day line Friday. The other indexes hit resistance.

Via Investor's Business Daily

Topics Economy

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value ↗

May 03, 2024

Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors.

Via Benzinga

Topics Earnings

Why Is WideOpenWest (WOW) Stock Up 30% Today? ↗

May 03, 2024

WideOpenWest stock is up on Friday after the technology company received a $4.80 per share in cash takeover offer for WOW shares.

Via InvestorPlace

Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up ↗

May 03, 2024

To gain an edge, this is what you need to know today.

Via Benzinga

AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company? ↗

May 03, 2024

Amgen (AMGN) stock is soaring after the company's CEO said he was "very encouraged" by interim data for Amgen's new weight-loss drug.

Via InvestorPlace

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗

May 03, 2024

Via Benzinga

Wall Street Looks To Feed Off Apple's Post-Earnings Power But Key Jobs Data May Upset The Cart: Analyst Says 'A Lot Of These Clouds Will Lift' If This Happens ↗

May 03, 2024

Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the all-important non-farm payrolls report.

Via Benzinga

Why Apple Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗

May 03, 2024

Via Benzinga

Amgen Stock Adds Good Weight After CEO's Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate ↗

May 03, 2024

MariTide, formerly AMG 133, is an injectable form of drug targeting two gut hormones — gastric inhibitory polypeptide receptor, or GIP, and glucagon-like peptide 1, or GLP-1.

Via Benzinga

Apple, Coinbase, Block, Amgen, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

May 02, 2024

Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66

Via Benzinga

Topics Stocks

AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

AMGN stock results show that Amgen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.